patients: 5% nasopharynx hypertrophy, 19% paranasal sinus disease, 5% mastoid involvement.
These data are interesting for two main reasons. First, it is important to highlight that 24% had ENT disorders not detected during clinical assessment; it is worth noting that these unrecognized ENT disorders were easily treatable (at follow up, this treatment also produced a cessation of headache). This means that for these patients MRI was in fact an exam that changed the treatment prescribed and/or increased it effectiveness. Second, the prevalence of significant alterations in our study was lower than the usually reported. 2 Jang et al. 1 describe the existing concerns about performing unnecessary neuroradiological exams. This poses serious ethical concerns, given on one hand the importance of the early identification of potentially life-threatening diseases and on the other hand the cost of these procedures both for the child (procedural sedation, X-rays in the case of CT) and for the health system. Moreover, inconsequential findings can lead to further unnecessary examinations and can be used as a defence to avoid the exploration of other potentially relevant factors, such as the psychological functioning of the child. 3, 4 This is especially important because of the relevance of psychological factors for treatment and prognosis of childhood headache is well established. 5 Our data support the need of robust prospective studies to better define clinical factors predicting (or excluding) the utility of MRI in children and adolescents with headache.
